Cardiovascular Ultrasound Equipment (Global Market)

Cardiovascular Treatment Equipment (Global Market)

Main Article: Cardiovascular Treatment Equipment (Global Market)

2016: Market size of $1.27 billion

In December 2016, the analytical company MarketsandMarkets presented a study on the global market for cardiovascular ultrasound equipment. Sales of such solutions are expected to increase, but at a low pace.

Researchers expect that in 2016, manufacturers' revenue from the sale of ultrasound devices for detecting heart and vascular diseases on a global scale will amount to $1.27 billion. In the next five years, this market will grow by an average of 5.4% annually and will reach $1.66 billion by 2021.

In 2016, the market for ultrasound equipment of the cardiovascular system will amount to $1.27 billion

Most of this equipment is purchased by hospitals, but the highest growth rates from 2016 to 2021 will be shown by the segment of solutions used in treatment or examination at home and when the patients themselves visit a medical institution (as opposed to inpatient treatment).

According to experts, the main factors that will contribute to the rise of the market in question will be the growing number of cases of cardiovascular disease, technological advances and advantages of echocardiography compared to invasive cardiac diagnostic procedures.

There are also barriers to the development of the market. These include a low payback when using such devices and a slow onset of economic effect from the introduction of new technologies, according to a study by MarketsandMarkets.^[1]

The following companies are called the largest manufacturers of ultrasound equipment for the examination of the cardiovascular system by analysts:

• GE Healthcare (USA);
• Philips Healthcare (Holland);
• Siemens Healthineers (Germany);
• Hitachi Medical Corporation (Japan);
• Toshiba Medical Systems (Japan).

Notes